全文获取类型
收费全文 | 3856篇 |
免费 | 247篇 |
国内免费 | 105篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 82篇 |
妇产科学 | 55篇 |
基础医学 | 494篇 |
口腔科学 | 107篇 |
临床医学 | 336篇 |
内科学 | 803篇 |
皮肤病学 | 182篇 |
神经病学 | 278篇 |
特种医学 | 199篇 |
外科学 | 404篇 |
综合类 | 136篇 |
预防医学 | 245篇 |
眼科学 | 70篇 |
药学 | 376篇 |
2篇 | |
中国医学 | 49篇 |
肿瘤学 | 375篇 |
出版年
2023年 | 18篇 |
2022年 | 74篇 |
2021年 | 108篇 |
2020年 | 52篇 |
2019年 | 70篇 |
2018年 | 91篇 |
2017年 | 92篇 |
2016年 | 109篇 |
2015年 | 126篇 |
2014年 | 174篇 |
2013年 | 188篇 |
2012年 | 256篇 |
2011年 | 233篇 |
2010年 | 150篇 |
2009年 | 122篇 |
2008年 | 180篇 |
2007年 | 215篇 |
2006年 | 152篇 |
2005年 | 183篇 |
2004年 | 154篇 |
2003年 | 129篇 |
2002年 | 127篇 |
2001年 | 97篇 |
2000年 | 76篇 |
1999年 | 71篇 |
1998年 | 64篇 |
1997年 | 73篇 |
1996年 | 66篇 |
1995年 | 60篇 |
1994年 | 49篇 |
1993年 | 41篇 |
1992年 | 43篇 |
1991年 | 43篇 |
1990年 | 30篇 |
1989年 | 33篇 |
1988年 | 56篇 |
1987年 | 46篇 |
1986年 | 33篇 |
1985年 | 29篇 |
1984年 | 16篇 |
1983年 | 19篇 |
1982年 | 19篇 |
1981年 | 17篇 |
1980年 | 21篇 |
1977年 | 20篇 |
1976年 | 16篇 |
1975年 | 12篇 |
1972年 | 22篇 |
1970年 | 16篇 |
1967年 | 12篇 |
排序方式: 共有4208条查询结果,搜索用时 15 毫秒
1.
2.
Anders Elm Pedersen Esben Gjerløff Wedebye Schmidt Jesper Freddie Sørensen Carsten Faber Boye Schnack Nielsen Kim Holmstrøm Silje Haukali Omland Peter Tougaard Søren Skov Bo Bang 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(7):547-555
TL1A is a TNF‐like cytokine which has been shown to co‐stimulate TH1 and TH17 responses during chronic inflammation. The expression of this novel cytokine has been investigated in inflammatory disorders like rheumatoid arthritis and inflammatory bowel disease, but little is known about expression and induction in psoriasis. Indeed, the pathogenesis in psoriasis is still not fully understood and it is speculated that cytokines other than TNF‐α are important in subsets of patients. Also, for patients with severe disease that are treated with systemic anti‐TNF‐α blockade, novel candidates to be used as disease and response biomarkers are of high interest. Here, we demonstrate TL1A expression in biopsies from psoriatic lesions. Also, we investigated spontaneous and induced TL1A secretion from PBMCs and blood levels from a cohort of psoriasis patients. Here, increased spontaneous secretion from PBMCs was observed as compared to healthy controls and a small subset of patients had highly elevated TL1A in the blood. Interestingly, activation of PBMCs with various cytokines showed a decreased sensitivity for TL1A activation in psoriasis patients compared to healthy controls.TL1A levels in blood and biopsies could not be correlated with disease activity with this patient cohort. Thus, additional large‐scale studies are warranted to investigate TL1A as a biomarker. 相似文献
3.
Frank Lindseth Thomas Lang? Jon Bang Toril A Nagelhus Hernes 《Computer aided surgery》2002,7(4):197-222
4.
5.
Carel Bron Michel Wensing Jo LM Franssen Rob AB Oostendorp 《BMC musculoskeletal disorders》2007,8(1):107
Background
Shoulder disorders are a common health problem in western societies. Several treatment protocols have been developed for the clinical management of persons with shoulder pain. However available evidence does not support any protocol as being superior over others. Systematic reviews provide some evidence that certain physical therapy interventions (i.e. supervised exercises and mobilisation) are effective in particular shoulder disorders (i.e. rotator cuff disorders, mixed shoulder disorders and adhesive capsulitis), but there is an ongoing need for high quality trials of physical therapy interventions. Usually, physical therapy consists of active exercises intended to strengthen the shoulder muscles as stabilizers of the glenohumeral joint or perform mobilisations to improve restricted mobility of the glenohumeral or adjacent joints (shoulder girdle). It is generally accepted that a-traumatic shoulder problems are the result of impingement of the subacromial structures, such as the bursa or rotator cuff tendons. Myofascial trigger points (MTrPs) in shoulder muscles may also lead to a complex of symptoms that are often seen in patients diagnosed with subacromial impingement or rotator cuff tendinopathy. Little is known about the treatment of MTrPs in patients with shoulder disorders. 相似文献6.
7.
8.
Palmar advancement flap with V-Y closure for thumb tip injuries 总被引:1,自引:0,他引:1
Hwang-hyun Bang MD Tadao Kojima MD Hiroyuki Hayashi MD 《The Journal of hand surgery》1992,17(5):933-934
The palmar advancement flap with V-Y closure was used in two patients with thumb tip injuries. This technique allows more distal advancement of the flap than does a conventional palmar advancement flap and does not require skin graft coverage. 相似文献
9.
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. 总被引:5,自引:0,他引:5
BACKGROUND. Deposition of fibrin in glomeruli and renal failure are characteristic features of the hemolytic uremic syndrome. An inhibitor of glomerular fibrinolysis has been detected in plasma from children with this disorder. In this study, we define the inhibitor and show that its plasma level is correlated with the outcome of the disease. METHODS AND RESULTS. Plasminogen-activator inhibitor type 1 (PAI-1) in plasma was measured with an assay employing a specific monoclonal antibody in 40 consecutive children hospitalized with the hemolytic uremic syndrome: 12 who recovered adequate renal function (serum creatinine, less than or equal to 2.0 mg per deciliter [177 mumol per liter]) without dialysis, 23 who recovered adequate renal function after peritoneal dialysis, and 5 who did not recover adequate renal function after undergoing dialysis. At presentation, plasma PAI-1 levels were higher in the patients with the hemolytic uremic syndrome than in nine children with other forms of acute renal failure. That the inhibitor was PAI-1 was indicated by the fact that it was a potent inhibitor of tissue plasminogen activator, was acid-resistant, and was not inhibited by denaturation (all unique traits of PAI-1) and that it was neutralized by an antibody specific for PAI-1. Multivariate discriminant-function analysis revealed that the duration of elevated PAI-1 activity was strongly correlated with the outcome of the disease (P less than 0.001). Peritoneal dialysis reduced plasma PAI-1 levels dramatically. CONCLUSIONS. Our studies suggest that PAI-1 is the circulating inhibitor of fibrinolysis in the hemolytic uremic syndrome. Normalization of plasma PAI-1 levels (e.g., by peritoneal dialysis) is correlated with improvement in renal function. However, the possibility that increased plasma levels of PAI-1 are either causes or effects of the hemolytic uremic syndrome is not unequivocally established by these studies. 相似文献
10.